Skip to main content

Attovia Therapeutics, Inc. (ATTO)

Sector
Healthcare
Industry
Biotechnology
Last price
$15.27
As of

Kresmion compiles this page from ATTO's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Attovia Therapeutics, Inc. (ATTO): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-02.

As of . Source: SEC EDGAR filings for ATTO. Method and limitations.

COMPANY DOSSIER

See the full ATTO dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for ATTO on one page. Preview it with sample data, then open it live with a free account.

Preview the ATTO dossier

Active events for ATTO

  • mediumEarnings below estimates

    Q2-2026: Missed consensus by 75.2%, EPS $-4.88 vs $-2.7846 estimate

FREE, NO ACCOUNT

Every event on ATTO, as it fires

New filings, 13F moves and cross asset events on ATTO land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter.

Recent SEC filings, ATTO

More data on ATTO

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in ATTO on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on ATTO in the last 180 days.

Upstream: SEC EDGAR filings for ATTO

Kresmion, "Attovia Therapeutics, Inc. (ATTO) institutional holdings and SEC filings", data as of 2026-09-20, https://kresmion.com/research/ATTO. Upstream data: SEC EDGAR filings for ATTO.

Link to this data (HTML):

<a href="https://kresmion.com/research/ATTO">Attovia Therapeutics, Inc. (ATTO) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow ATTO on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to ATTO for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the ATTO dossier
Share

The ATTO intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.